硬化性黏液水肿：1例对静脉注射免疫球蛋白有临床及组织学反应的病例。
Scleromyxedema: a case clinically and histologically responsive to intravenous immunoglobulin.
作者信息
Caudill Leslie, Howell Eric
机构信息
East Carolina University Dermatology, Greenville, North Carolina.
Eastern Dermatology, Greenville, North Carolina.
出版信息
J Clin Aesthet Dermatol. 2014 May;7(5):45-7.
Abstract
The authors report a 60-year-old man who presented with a rash and developed ataxia, confusion, slurring of speech, and disorientation that prompted hospitalization. A diagnosis of generalized scleromyxedema with neurological features was eventually made and the patient was treated with intravenous immunoglobulin. The patient showed clinical response to intravenous immunoglobulin therapy, and repeat biopsy showed histological clearance of increased fibroblasts and mucin deposition, demonstrating both clinical and histological response to intravenous immunoglobulin.
摘要
作者报告了一名60岁男性，该患者出现皮疹，并逐渐出现共济失调、意识模糊、言语不清和定向障碍，这些症状促使其住院治疗。最终诊断为伴有神经症状的泛发性硬化性黏液水肿，患者接受了静脉注射免疫球蛋白治疗。患者对静脉注射免疫球蛋白治疗有临床反应，重复活检显示成纤维细胞增多和黏蛋白沉积的组织学清除，表明对静脉注射免疫球蛋白有临床和组织学反应。
相似文献
1
Scleromyxedema: a case clinically and histologically responsive to intravenous immunoglobulin.硬化性黏液水肿：1例对静脉注射免疫球蛋白有临床及组织学反应的病例。
J Clin Aesthet Dermatol. 2014 May;7(5):45-7.
2
Scleromyxedema with multiple systemic involvement: Successful treatment with intravenous immunoglobulin.伴有多系统受累的硬化性黏液水肿：静脉注射免疫球蛋白治疗成功
Dermatol Ther. 2020 May;33(3):e13378. doi: 10.1111/dth.13378. Epub 2020 Apr 15.
3
Scleromyxedema with an interstitial granulomatous-like pattern: a rare histologic variant mimicking granuloma annulare.伴有间质肉芽肿样模式的硬化性黏液水肿：一种罕见的组织学变异型，酷似环状肉芽肿。
J Cutan Pathol. 2010 Oct;37(10):1084-7. doi: 10.1111/j.1600-0560.2009.01386.x. Epub 2009 Jul 22.
4
Scleromyxedema in a 21 year old female patient with acute lymphoblastic leukemia: a case report.21 岁女性急性淋巴细胞白血病合并硬肿性黏液水肿 1 例报告
BMC Dermatol. 2020 Dec 4;20(1):18. doi: 10.1186/s12895-020-00118-7.
5
[Marked improvement in scleromyxedema with high-dose intravenous immunoglobulin].[大剂量静脉注射免疫球蛋白治疗硬化性黏液水肿取得显著改善]
Hautarzt. 2007 Jun;58(6):525-8. doi: 10.1007/s00105-006-1261-1.
6
[Atypical scleromyxedema with a granulomatous histological pattern and delayed sclerosis].[具有肉芽肿性组织学模式和延迟性硬化的非典型硬化性黏液水肿]
Ann Dermatol Venereol. 2016 May;143(5):382-6. doi: 10.1016/j.annder.2016.01.010. Epub 2016 Mar 8.
7
Granulomatous scleromyxedema: case report and literature review.肉芽肿性硬化性黏液水肿：病例报告及文献综述
Am J Dermatopathol. 2015 Mar;37(3):240-5. doi: 10.1097/DAD.0b013e3182932ac0.
8
Intravenous immunoglobulin therapy for scleromyxedema: a case report and review of literature.静脉注射免疫球蛋白治疗硬化性黏液水肿：一例病例报告及文献综述
J Drugs Dermatol. 2010 Mar;9(3):263-5.
9
10
Long-Term Efficacy of Treatment with Intravenous Immunoglobulin in Scleromyxedema.硬肿性黏液水肿的静脉注射免疫球蛋白治疗的长期疗效。
Acta Dermatovenerol Croat. 2020 Jul;28(1):24-28.
引用本文的文献
1
Combination of intravenous immunoglobulin, oral prednisone, and methotrexate for managing scleromyxedema: case report and literature discussion.静脉注射免疫球蛋白、口服泼尼松和甲氨蝶呤联合治疗硬化性黏液水肿：病例报告及文献讨论
Dermatol Reports. 2023 Aug 24;16(2):9803. doi: 10.4081/dr.2023.9803. eCollection 2024 Jun 14.
2
Case report: Scleromyxedema associated with a monoclonal gammapathy: Successful treatment with intravenous immunoglobulins.病例报告：硬肿性黏液水肿伴单克隆丙种球蛋白血症：静脉注射免疫球蛋白治疗成功。
Front Immunol. 2023 Jan 13;13:1099918. doi: 10.3389/fimmu.2022.1099918. eCollection 2022.
3
Clinical Characteristics and Treatment Outcomes of Scleromyxedema: A 10-Year Retrospective Survey.硬肿病的临床特征与治疗结果：一项10年回顾性调查
Case Rep Dermatol. 2022 Jun 27;14(2):178-183. doi: 10.1159/000525211. eCollection 2022 May-Aug.
4
Scleromyxedema in a 21 year old female patient with acute lymphoblastic leukemia: a case report.21 岁女性急性淋巴细胞白血病合并硬肿性黏液水肿 1 例报告
BMC Dermatol. 2020 Dec 4;20(1):18. doi: 10.1186/s12895-020-00118-7.
5
Characterization of circulating myeloma tumor cells by next generation flowcytometry in scleromyxedema patient: a case report.采用新一代流式细胞术对硬化性黏液水肿患者循环骨髓瘤肿瘤细胞进行表征：一例报告
Medicine (Baltimore). 2020 Jul 2;99(27):e20726. doi: 10.1097/MD.0000000000020726.
6
Scleroderma Mimickers.硬皮病模仿者
Curr Treatm Opt Rheumatol. 2016 Mar;2(1):69-84. doi: 10.1007/s40674-016-0038-7. Epub 2016 Feb 5.
7
Scleromyxedema without Paraproteinemia: Treatment with Thalidomide and Prednisolone.无副蛋白血症的硬化性黏液水肿：沙利度胺和泼尼松龙治疗
Case Rep Dermatol. 2016 Nov 21;8(3):327-332. doi: 10.1159/000452319. eCollection 2016 Sep-Dec.
本文引用的文献
1
Scleromyxedema presenting with neurologic symptoms: a case report and review of the literature.表现为神经症状的硬化性黏液水肿：一例报告并文献复习
Cutis. 2010 Mar;85(3):137-40.
2
Scleromyxoedema: a cause for unexplained encephalopathy and myositis.硬肿性黏液水肿：不明原因脑病和肌炎的病因。
Clin Exp Dermatol. 2010 Oct;35(7):746-8. doi: 10.1111/j.1365-2230.2010.03807.x.
3
Intravenous immunoglobulin therapy for scleromyxedema: a case report and review of literature.静脉注射免疫球蛋白治疗硬化性黏液水肿：一例病例报告及文献综述
J Drugs Dermatol. 2010 Mar;9(3):263-5.
4
[Efficacy of intravenous immunoglobulin in the treatment of scleromyxoedema].静脉注射免疫球蛋白治疗硬化性黏液水肿的疗效
Ann Dermatol Venereol. 2010 Jan;137(1):48-52. doi: 10.1016/j.annder.2009.11.010. Epub 2009 Dec 29.
5
Treatment of scleromyxedema and the dermatoneuro syndrome with intravenous immunoglobulin.静脉注射免疫球蛋白治疗硬化性黏液水肿和皮肤神经综合征。
J Am Acad Dermatol. 2009 Jun;60(6):1037-41. doi: 10.1016/j.jaad.2008.11.013. Epub 2009 Feb 26.
6
Scleromyxedema: a case series highlighting long-term outcomes of treatment with intravenous immunoglobulin (IVIG).硬化性黏液水肿：一个突出静脉注射免疫球蛋白（IVIG）治疗长期疗效的病例系列。
Medicine (Baltimore). 2008 Jan;87(1):10-20. doi: 10.1097/MD.0b013e3181630835.
7
Scleromyxedema diagnosis following unexplained encephalopathy.不明原因脑病后硬皮黏液水肿的诊断
Eur J Dermatol. 2008 Jan-Feb;18(1):78-9. doi: 10.1684/ejd.2007.0315. Epub 2007 Dec 18.
Zotero 插件